Moolec Science Statistics
Total Valuation
Moolec Science has a market cap or net worth of $32.67 million. The enterprise value is $42.16 million.
Important Dates
The next estimated earnings date is Thursday, December 12, 2024, before market open.
| Earnings Date | Dec 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Moolec Science has 38.44 million shares outstanding. The number of shares has increased by 9.88% in one year.
| Current Share Class | 38.44M |
| Shares Outstanding | 38.44M |
| Shares Change (YoY) | +9.88% |
| Shares Change (QoQ) | -4.10% |
| Owned by Insiders (%) | 14.17% |
| Owned by Institutions (%) | 0.14% |
| Float | 5.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.76 |
| Forward PS | 4.77 |
| PB Ratio | 4.82 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 2.15.
| Current Ratio | 1.69 |
| Quick Ratio | 0.84 |
| Debt / Equity | 2.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.76 |
Financial Efficiency
Return on equity (ROE) is -86.42% and return on invested capital (ROIC) is -33.00%.
| Return on Equity (ROE) | -86.42% |
| Return on Assets (ROA) | -19.21% |
| Return on Capital (ROIC) | -33.00% |
| Revenue Per Employee | $108,175 |
| Profits Per Employee | -$140,620 |
| Employee Count | 52 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 1.53 |
Taxes
| Income Tax | -1.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.47% in the last 52 weeks. The beta is -0.54, so Moolec Science's price volatility has been lower than the market average.
| Beta (5Y) | -0.54 |
| 52-Week Price Change | -66.47% |
| 50-Day Moving Average | 0.87 |
| 200-Day Moving Average | 1.16 |
| Relative Strength Index (RSI) | 47.41 |
| Average Volume (20 Days) | 11,509 |
Short Selling Information
The latest short interest is 183,320, so 0.48% of the outstanding shares have been sold short.
| Short Interest | 183,320 |
| Short Previous Month | 137,598 |
| Short % of Shares Out | 0.48% |
| Short % of Float | 3.41% |
| Short Ratio (days to cover) | 5.03 |
Income Statement
In the last 12 months, Moolec Science had revenue of $5.63 million and -$7.31 million in losses. Loss per share was -$0.19.
| Revenue | 5.63M |
| Gross Profit | 472,581 |
| Operating Income | -9.04M |
| Pretax Income | -8.08M |
| Net Income | -7.31M |
| EBITDA | -8.16M |
| EBIT | -9.04M |
| Loss Per Share | -$0.19 |
Full Income StatementBalance Sheet
The company has $5.39 million in cash and $14.68 million in debt, giving a net cash position of -$9.29 million or -$0.24 per share.
| Cash & Cash Equivalents | 5.39M |
| Total Debt | 14.68M |
| Net Cash | -9.29M |
| Net Cash Per Share | -$0.24 |
| Equity (Book Value) | 6.82M |
| Book Value Per Share | 0.18 |
| Working Capital | 5.60M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.33 million and capital expenditures -$158,283, giving a free cash flow of -$9.49 million.
| Operating Cash Flow | -9.33M |
| Capital Expenditures | -158,283 |
| Free Cash Flow | -9.49M |
| FCF Per Share | -$0.25 |
Full Cash Flow StatementMargins
Gross margin is 8.40%, with operating and profit margins of -160.76% and -129.99%.
| Gross Margin | 8.40% |
| Operating Margin | -160.76% |
| Pretax Margin | -148.61% |
| Profit Margin | -129.99% |
| EBITDA Margin | -145.00% |
| EBIT Margin | -160.76% |
| FCF Margin | -221.53% |
Dividends & Yields
Moolec Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.88% |
| Shareholder Yield | -9.88% |
| Earnings Yield | -22.25% |
| FCF Yield | -28.86% |
Analyst Forecast
The average price target for Moolec Science is $6.00, which is 605.88% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.00 |
| Price Target Difference | 605.88% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 108.34% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Moolec Science has an Altman Z-Score of -1.34 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.34 |
| Piotroski F-Score | 3 |